Transcatheter Aortic Valve Replacement
The Lotus™ Valve System
The Lotus Valve System is a differentiated second-generation Transcatheter Aortic Valve Replacement (TAVR) technology, which consists of a pre-loaded, stent-mounted tissue valve prosthesis and catheter delivery system for guidance and percutaneous placement of the valve. The low-profile delivery system and introducer sheath are designed to enable predictable and precise placement, as well as bi-directional atraumatic repositioning and retrieval at any time prior to release of the aortic valve implant. The device also employs a unique Adaptive Seal feature designed to minimize the incidence of paravalvular regurgitation.
The Lotus Valve System is an investigational device worldwide, limited by applicable law to investigational use and not available for sale. The device was developed by Sadra Medical, which Boston Scientific acquired in 2011.
REPRISE Clinical Trial Press Releases
May 22, 2013
Boston Scientific Reports Lotus (TM) Valve System Met Primary Performance Endpoint In Reprise II Trial
Oct 10, 2012
First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System
May 15, 2012
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial